RX
RxSight, Inc.
RXST · NASDAQ
$5.96 -4.79% (-$0.30)
1M -15.58%
Market Cap $246.7M
P/E Ratio -
Div. Yield -
ROE 17.35%
Bulios Fair Price
$3.02
49.3% downside
Trenutna cena
$5.96
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RXST trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
88 /100
Cheap P/B 0.94x
P/S 1.93x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 45.28%
Rev. growth 40.00%
FCF growth N/A
Profitability
20 /100
Weak Net margin 36.80%
Op. margin 43.20%
FCF margin 21.29%
Quality
5 /100
Poor ROE 17.35%
ROA 13.31%
Asset turnover 0.36x
Debt
69 /100
Low Current ratio 4.07x
Int. coverage -3,121.60x
Debt/Equity 0.04x
Stability
30 /100
Unstable Rev. volatility 44.10%
EPS volatility 46.01%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RXST
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Aziz Mottiwala
Employees
461
Headquarters
Aliso Viejo
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report